Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 8
1946 56
1947 43
1948 47
1949 45
1950 71
1951 98
1952 124
1953 118
1954 113
1955 121
1956 128
1957 119
1958 95
1959 125
1960 121
1961 118
1962 130
1963 246
1964 309
1965 202
1966 193
1967 188
1968 220
1969 201
1970 175
1971 181
1972 155
1973 183
1974 166
1975 143
1976 178
1977 164
1978 152
1979 164
1980 178
1981 151
1982 184
1983 207
1984 193
1985 190
1986 190
1987 233
1988 245
1989 262
1990 281
1991 228
1992 271
1993 259
1994 224
1995 229
1996 222
1997 251
1998 265
1999 253
2000 254
2001 244
2002 282
2003 246
2004 300
2005 327
2006 339
2007 349
2008 396
2009 424
2010 452
2011 517
2012 500
2013 640
2014 714
2015 689
2016 735
2017 793
2018 758
2019 766
2020 814
2021 862
2022 1041
2023 985
2024 529

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21,525 results

Results by year

Filters applied: . Clear all
Page 1
International Guidelines for the Diagnosis and Management of Hyperinsulinism.
De Leon DD, Arnoux JB, Banerjee I, Bergada I, Bhatti T, Conwell LS, Fu J, Flanagan SE, Gillis D, Meissner T, Mohnike K, Pasquini TLS, Shah P, Stanley CA, Vella A, Yorifuji T, Thornton PS. De Leon DD, et al. Horm Res Paediatr. 2024;97(3):279-298. doi: 10.1159/000531766. Epub 2023 Jul 14. Horm Res Paediatr. 2024. PMID: 37454648 Free PMC article. Review.
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial.
Laffel LM, Danne T, Klingensmith GJ, Tamborlane WV, Willi S, Zeitler P, Neubacher D, Marquard J; DINAMO Study Group. Laffel LM, et al. Lancet Diabetes Endocrinol. 2023 Mar;11(3):169-181. doi: 10.1016/S2213-8587(22)00387-4. Epub 2023 Feb 1. Lancet Diabetes Endocrinol. 2023. PMID: 36738751 Free PMC article. Clinical Trial.
Examining the Acute Glycemic Effects of Different Types of Structured Exercise Sessions in Type 1 Diabetes in a Real-World Setting: The Type 1 Diabetes and Exercise Initiative (T1DEXI).
Riddell MC, Li Z, Gal RL, Calhoun P, Jacobs PG, Clements MA, Martin CK, Doyle Iii FJ, Patton SR, Castle JR, Gillingham MB, Beck RW, Rickels MR; T1DEXI Study Group. Riddell MC, et al. Diabetes Care. 2023 Apr 1;46(4):704-713. doi: 10.2337/dc22-1721. Diabetes Care. 2023. PMID: 36795053 Free PMC article. Clinical Trial.
A Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials.
Spanakis EK, Cook CB, Kulasa K, Aloi JA, Bally L, Davis G, Dungan KM, Galindo RJ, Mendez CE, Pasquel FJ, Shah VN, Umpierrez GE, Aaron RE, Tian T, Yeung AM, Huang J, Klonoff DC. Spanakis EK, et al. J Diabetes Sci Technol. 2023 Nov;17(6):1527-1552. doi: 10.1177/19322968231191104. Epub 2023 Aug 17. J Diabetes Sci Technol. 2023. PMID: 37592726 Free PMC article.
Perioperative glycaemic control for people with diabetes undergoing surgery.
Bellon F, Solà I, Gimenez-Perez G, Hernández M, Metzendorf MI, Rubinat E, Mauricio D. Bellon F, et al. Cochrane Database Syst Rev. 2023 Aug 1;8(8):CD007315. doi: 10.1002/14651858.CD007315.pub3. Cochrane Database Syst Rev. 2023. PMID: 37526194 Free PMC article. Review.
Severe quinolone-induced hypoglycemia.
Lafita López A, Ocabo Buil P, Arche Banzo MJ. Lafita López A, et al. Med Clin (Barc). 2023 Sep 8;161(5):229. doi: 10.1016/j.medcli.2023.04.024. Epub 2023 May 24. Med Clin (Barc). 2023. PMID: 37236836 English, Spanish. No abstract available.
A Randomized Controlled Trial Comparing the Efficacy and Safety of IDegLira Versus Basal-Bolus in Patients With Poorly Controlled Type 2 Diabetes and Very High HbA1c ≥9-15%: DUAL HIGH Trial.
Galindo RJ, Moazzami B, Scioscia MF, Zambrano C, Albury BS, Saling J, Vellanki P, Pasquel FJ, Davis GM, Fayfman M, Peng L, Umpierrez GE. Galindo RJ, et al. Diabetes Care. 2023 Sep 1;46(9):1640-1645. doi: 10.2337/dc22-2426. Diabetes Care. 2023. PMID: 37459574 Free PMC article. Clinical Trial.
21,525 results
You have reached the last available page of results. Please see the User Guide for more information.